Quarterly report pursuant to Section 13 or 15(d)

SEGMENT REPORTING - Net Sales and Segment Profit (Details)

v3.22.2
SEGMENT REPORTING - Net Sales and Segment Profit (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Segment Reporting Information [Line Items]        
Segment Net Sales: $ 4,657 $ 3,672 $ 9,881 $ 7,149
Segment Profit (Loss): 1,304 1,768 3,342 3,908
Non-cash share-based compensation     (1,648) (4,873)
Depreciation and amortization (537) (524) (1,054) (1,103)
Loss from operations (8,198) (9,603) (20,091) (17,371)
Loss on debt extinguishment 0 0 2,263 0
(Gain) loss on remeasurement of warrant liability (1,323) (1,176) (1,813) 3,675
Gain on investment (6,851) 0 (6,851) 0
Foreign exchange loss 307 80 652 839
Interest and amortization of debt issuance cost 652 920 2,770 1,898
Other expense (income), net 63 (485) 10 (1,087)
Loss before loss from equity investment (1,046) (8,942) (17,122) (22,696)
Operating Segments        
Segment Reporting Information [Line Items]        
Segment Net Sales: 4,657 3,672 9,881 7,149
Segment Profit (Loss): (4,672) (2,970) (12,012) (5,222)
Operating Segments | Cannabinoid        
Segment Reporting Information [Line Items]        
Segment Net Sales: 1,299 579 3,290 1,256
Segment Profit (Loss): (5,338) (3,604) (13,026) (6,468)
Operating Segments | Non-Cannabinoid        
Segment Reporting Information [Line Items]        
Segment Net Sales: 3,358 3,093 6,591 5,893
Segment Profit (Loss): 666 634 1,014 1,246
Other        
Segment Reporting Information [Line Items]        
Unallocated corporate expenses (1,841) (2,786) (5,377) (6,173)
Non-cash share-based compensation (1,148) (3,323) (1,648) (4,873)
Depreciation and amortization (537) (524) (1,054) (1,103)
Loss from operations $ (8,198) $ (9,603) $ (20,091) $ (17,371)